Cargando…

Real-World Anti-Vascular Endothelial Growth Factor Therapy Outcomes in Myopic Choroidal Neovascularization

AIM: Evaluation of real-world outcomes of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy in the primary treatment of choroidal neovascularization (CNV) secondary to pathological myopia. PATIENTS AND METHODS: A retrospective cohort analysis of treatment naive patients with m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhatia, Devangna, Mehta, Alexander, DaCosta, Joanna, Crothers, Oonagh, Talks, James Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240844/ https://www.ncbi.nlm.nih.gov/pubmed/34211264 http://dx.doi.org/10.2147/OPTH.S311816

Ejemplares similares

Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration
por: Cheema, Muhammad Raza, et al.
Publicado: (2021)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan, Colin S, et al.
Publicado: (2017)

Characteristics and response of subretinal hyperreflective material to anti-vascular endothelial growth factor in myopic choroidal neovascularization
por: Huang, Chien-Jung, et al.
Publicado: (2023)

Baseline predictors for good visual gains after anti-vascular endothelial growth factor therapy for myopic choroidal neovascularization
por: Hsu, Cherng-Ru, et al.
Publicado: (2022)

Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study
por: Hamilton, Robin D., et al.
Publicado: (2020)

Real-World Treatment Intensity and Patterns in Patients With Myopic Choroidal Neovascularization: Common Data Model in Ophthalmology
por: Bui, Manh-Hung, et al.
Publicado: (2023)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

Spectral domain-optical coherence tomography retinal biomarkers in choroidal neovascularization of multifocal choroiditis, myopic choroidal neovascularization, and idiopathic choroidal neovascularization
por: Gao, Rui, et al.
Publicado: (2021)

Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization
por: Uematsu, Sato, et al.
Publicado: (2021)

Current and emerging treatment options for myopic choroidal neovascularization
por: El Matri, Leila, et al.
Publicado: (2015)

Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians
por: Milani, Paolo, et al.
Publicado: (2016)

Result of intravitreal aflibercept injection for myopic choroidal neovascularization
por: Chen, Shih-Lin, et al.
Publicado: (2021)

Surgical choroidal neovascular membrane removal in the era of anti-vascular endothelial growth factor agents
por: Nagpal, Manish, et al.
Publicado: (2009)

Response of Pediatric Choroidal Neovascularization to Anti-Vascular Endothelial Growth Factor
por: Ruparelia, Sunil, et al.
Publicado: (2021)

Morphological parameters of myopic choroidal neovascularization as predictive factors of anti-VEGF treatment response
por: Castellino, Niccolò, et al.
Publicado: (2022)

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
por: Wang, Jia-Kang, et al.
Publicado: (2018)

Anti-vascular endothelial growth factors for choroidal neovascularization secondary to choroidal osteoma: Long-term results
por: Lekha, T., et al.
Publicado: (2015)

Optical Coherence Tomography Angiography-Based Quantitative Assessment of Morphologic Changes in Active Myopic Choroidal Neovascularization During Anti-vascular Endothelial Growth Factor Therapy
por: Wang, Yao, et al.
Publicado: (2021)

Intravitreal conbercept for choroidal neovascularisation secondary to pathological myopia in a real‐world setting in China: Intravitreal conbercept was safe and effective in treating myopic choroidal neovascularization
por: Nie, Xin, et al.
Publicado: (2021)

Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan
por: Ohno-Matsui, Kyoko, et al.
Publicado: (2018)

Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application
por: Zhang, Yan, et al.
Publicado: (2015)

Risk factors for myopic choroidal neovascularization-related macular atrophy after anti-VEGF treatment
por: Bae, Ki Woong, et al.
Publicado: (2022)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis, Dimitrios, et al.
Publicado: (2017)

Results of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in Inflammatory Choroidal Neovascularization
por: Zina, Sourour, et al.
Publicado: (2021)

Choroidal Morphologic and Vascular Features in Patients With Myopic Choroidal Neovascularization and Different Levels of Myopia Based on Image Binarization of Optical Coherence Tomography
por: Wang, Xinglin, et al.
Publicado: (2022)

Prognostic value of myopic disk deformation in myopic choroidal neovascularization: A 6-year follow-up study
por: Han, Ye Eun, et al.
Publicado: (2022)

Autofluorescence findings and role of anti-vascular endothelial growth factor in inflammatory choroidal neovascular membrane
por: Chhablani, Jay Kumar
Publicado: (2010)

Evaluation of efficacy and recurrence for anti-vascular endothelial growth factor therapy in idiopathic choroidal neovascularization
por: Wu, Qianru, et al.
Publicado: (2020)

Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization
por: Chhablani, Jay Kumar
Publicado: (2010)

High‑dose aflibercept injection has striking effects on myopic choroidal neovascularization
por: Zhu, Wei, et al.
Publicado: (2023)

Lycopene inhibits endothelial‐to‐mesenchymal transition of choroidal vascular endothelial cells in laser‐induced mouse choroidal neovascularization
por: Li, Lele, et al.
Publicado: (2023)

Three cases of macular retinal detachment exacerbated during follow-up with myopic foveoschisis around myopic choroidal neovascularization()()
por: Sayanagi, Kaori, et al.
Publicado: (2023)

Long-Term Effect of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Injections in Choroidal Neovascularization Secondary to Angioid Streaks
por: Torres-Costa, Sónia, et al.
Publicado: (2022)

Choroidal thickness and choriocapillaris vascular density in myopic anisometropia
por: Liu, Xinting, et al.
Publicado: (2021)

Paediatric choroidal neovascular membrane secondary to toxoplasmosis treated successfully with anti-vascular endothelial growth factor
por: Mathur, Gaurav, et al.
Publicado: (2014)

Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction
por: Yeo, Natalie Jia Ying, et al.
Publicado: (2019)

Results of Ranibizumab Treatment of the Myopic Choroidal Neovascular Membrane according to the Axial Length of the Eye
por: Stepanov, Alexandr, et al.
Publicado: (2020)

Ten-Year Outcomes of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization: Analysis of Prognostic Factors
por: Mallone, Fabiana, et al.
Publicado: (2021)

RELATIONSHIP BETWEEN MYOPIC CHOROIDAL NEOVASCULARIZATION ACTIVITY AND PERFORATING SCLERAL VESSELS IN HIGH MYOPIA
por: Ruiz-Medrano, Jorge, et al.
Publicado: (2022)

An ImageJ macro tool for OCTA-based quantitative analysis of Myopic Choroidal neovascularization
por: Deshpande, Aadit, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3ucc1pn6imq0r20o4f514c5lvf